Literature DB >> 15221080

Cardiac reconstruction in the Jurassic Period.

Friedrich C Luft1.   

Abstract

Mesh：

Year:  2004        PMID： 15221080     DOI： 10.1007/s00109-004-0568-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  11 in total

1.  Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy.

Authors:  Albert A Hagège; Claire Carrion; Philippe Menasché; Jean-Thomas Vilquin; Denis Duboc; Jean-Pierre Marolleau; Michel Desnos; Patrick Bruneval
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

2.  Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor.

Authors:  Husnain Kh Haider; Lei Ye; Shujia Jiang; Ruowen Ge; Peter K Law; Terrance Chua; Phillip Wong; Eugene K W Sim
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

Review 3.  Regenerative capacity of the myocardium: implications for treatment of heart failure.

Authors:  Rüdiger von Harsdorf; Philip A Poole-Wilson; Rainer Dietz
Journal:  Lancet       Date:  2004-04-17       Impact factor: 79.321

4.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

Authors:  Christof Stamm; Bernd Westphal; Hans-Dieter Kleine; Michael Petzsch; Christian Kittner; Heiko Klinge; Carl Schümichen; Christoph A Nienaber; Mathias Freund; Gustav Steinhoff
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

5.  Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

Authors:  P Richard Vulliet; Melanie Greeley; S Mitchell Halloran; Kristin A MacDonald; Mark D Kittleson
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

6.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

Authors:  Hyun-Jae Kang; Hyo-Soo Kim; Shu-Ying Zhang; Kyung-Woo Park; Hyun-Jai Cho; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

Review 7.  Stem-cell transplantation in myocardial infarction: a status report.

Authors:  Michael S Lee; Raj R Makkar
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

8.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Authors:  Arman T Askari; Samuel Unzek; Zoran B Popovic; Corey K Goldman; Farhad Forudi; Matthew Kiedrowski; Aleksandr Rovner; Stephen G Ellis; James D Thomas; Paul E DiCorleto; Eric J Topol; Marc S Penn
Journal:  Lancet       Date:  2003-08-30       Impact factor: 79.321

9.  Adult bone marrow stem cells regenerate myocardium in ischemic heart disease.

Authors:  Donald Orlic
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.